Cargando…

Protecting intubated patients from the threat of antimicrobial resistant infections with monoclonal antibodies

Detalles Bibliográficos
Autores principales:	Baker, Stephen, Kellam, Paul, Krishna, Aishwarya, Reece, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831774/ https://www.ncbi.nlm.nih.gov/pubmed/33521719 http://dx.doi.org/10.1016/S2666-5247(20)30126-9

Ejemplares similares

Antimicrobial-resistant Shigella: where do we go next?
por: Baker, Stephen, et al.
Publicado: (2023)

Developing therapeutic monoclonal antibodies at pandemic pace
por: Kelley, Brian
Publicado: (2020)

A threat to decentralised care for drug-resistant tuberculosis
por: Gray, Adam T, et al.
Publicado: (2020)

Antimicrobial use, drug-resistant infections and COVID-19
por: Rawson, Timothy M., et al.
Publicado: (2020)

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19
por: Shapiro, Adrienne E, et al.
Publicado: (2022)

Looming threat of COVID-19 infection in Africa: act collectively, and fast
por: Nkengasong, John N, et al.
Publicado: (2020)

A too familiar threat
por: de-Graft Aikins, Ama
Publicado: (2021)

Eye-tracking during newborn intubations
por: Buehler, Philipp K., et al.
Publicado: (2023)

The overlooked pandemic of antimicrobial resistance
por: Laxminarayan, Ramanan
Publicado: (2022)

The pandemic legacy of antimicrobial resistance in the USA
por: Patel, Jay, et al.
Publicado: (2022)

Enhancing preparedness for tackling new epidemic threats
por: Zumla, Alimuddin, et al.
Publicado: (2017)

Ranking threats to biodiversity and why it doesn’t matter
por: Bellard, Céline, et al.
Publicado: (2022)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

A metabolic perspective into antimicrobial tolerance and resistance
por: Bhusal, Ram Prasad, et al.
Publicado: (2022)

The contribution of human conflict to the development of antimicrobial resistance
por: Pallett, Scott J. C., et al.
Publicado: (2023)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

COVID-19 threat and frontline paediatric care professionals
por: Koutsaftiki, Chryssie, et al.
Publicado: (2020)

Monoclonals for patients hospitalised with COVID-19
por: Pogue, Jason M, et al.
Publicado: (2022)

Rising antimicrobial resistance: an evolving epidemic in a pandemic
por: Manesh, Abi, et al.
Publicado: (2021)

Prone positioning in non-intubated patients with COVID-19: raising the bar
por: Munshi, Laveena, et al.
Publicado: (2020)

Pandemics of People and Plants: Which Is the Greater Threat to Food Security?
por: He, Sylvia, et al.
Publicado: (2020)

Transforming or tinkering: the world remains unprepared for the next pandemic threat
por: Clark, Helen, et al.
Publicado: (2022)

Mass testing to end the COVID-19 public health threat
por: Philippe, Cecile, et al.
Publicado: (2023)

The Lancet Commission on 21st-Century Global Health Threats
por: Kanem, Natalia, et al.
Publicado: (2023)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

COVID-19 drug practices risk antimicrobial resistance evolution
por: Afshinnekoo, Ebrahim, et al.
Publicado: (2021)

Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission
por: Lee, Vernon J, et al.
Publicado: (2020)

COVID-19 threat and the 1918 Spanish flu outbreak: The following day
por: Mammas, Ioannis N., et al.
Publicado: (2020)

How better pandemic and epidemic intelligence will prepare the world for future threats
por: Morgan, Oliver W., et al.
Publicado: (2022)

Dissecting antibody-mediated protection against SARS-CoV-2
por: Zohar, Tomer, et al.
Publicado: (2020)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Confronting the persisting threat of the Middle East respiratory syndrome to global health security
por: Perlman, Stanley, et al.
Publicado: (2020)

Alloimmunization against Fy3 is a serious threat in the era of cell therapy
por: Lemaire, Baptiste, et al.
Publicado: (2022)

The emerging antimicrobial resistance crisis during the COVID-19 surge in China
por: Wang, Zhicheng, et al.
Publicado: (2023)

Co-designing community-based interventions to tackle antimicrobial resistance (AMR): what to include and why
por: Mitchell, Jessica, et al.
Publicado: (2023)

Tracheal Intubation Awake or Under Anesthesia for Potential Difficult Airway: Look Before You Leap
por: Xue, Fu-Shan, et al.
Publicado: (2018)

A genomics network established to respond rapidly to public health threats in South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
por: Franco-Paredes, Carlos, et al.
Publicado: (2022)

Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
por: Strathdee, Steffanie A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ql295k1h0q306s6qu2evebed8r